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Abstract 
A simple, specific, rapid, economical and accurate reverse phase high performance liquid chromatographic 
method was developed for simultaneous estimation of Etodolac and Paracetamol in bulk drug and tablet 
dosage form. Separation was achieved by cap cell pack C-18 column having 250 mm× 4.6 mm i.d. in isocratic 
mode, with mobile phase containing 25 nM potassium dihydrogen phosphate buffer (adjusted to pH 6.1 using 
ortho phosphoric acid) : methanol (40:60). The flow rate was 1.0 ml/min and effluents were monitored at 235 
nm. The retention time of Etodolac and Paracetamol were 3.19 min and 6.08 min respectively. The linearity 
for Etodolac and Paracetamol were in the range of 10-100 ȝg/ml. The recoveries of Etodolac and Paracetamol 
were found in the range of 99.27-99.78 % and 99.74-99.88 % respectively. The proposed method was 
validated as per ICH and USP guidelines and successfully applied to the estimation of Etodolac and 
Paracetamol in bulk drug and tablet dosage form. 
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1. Introduction 
1.1 Analytical Chemistry
1-5
 
Analytical chemistry is the analysis of 
material samples to gain anunderstanding of their 
chemical composition and structure.During last few 
decades, analytical chemistry has witnessed 
extensivedevelopment in terms of sophistication, 
quantitation and Instrumentation.  Consequently, 
newer analytical techniques (such as hyphenated 
techniques FTIR,GCMS, LCMS, HPLC, HPTLC etc.) 
and their areas of application have increased 
considerably because of the stringent requirements for 
testing and monitoring of thedrugs for approval; the  
demand on quality, validation data and performance 
of analytical methods have gained an importance. 
Analytical chemistry requires broad background 
knowledge of chemical and physical concepts. These 
hypermedia documents contain links to the 
fundamental principles that underlay the different 
analytical methods. With a fundamental 
understanding of analytical methods, a scientist faced 
with a difficult analytical problem can apply the most 
appropriate techniques. A fundamental understanding 
also makes it easier to identify when a particular 
problem cannot be solved by traditional methods, and 
gives an analyst the knowledge that is needed to 
develop creative approaches or new analytical 
methods. During the development of new drug 
product, detailed chemical studies must be made of 
raw materials, synthetic intermediates, the drug 
substance itself and the final formulated product. The 
set of analytical procedures developed to control the 
quality of the final marketed product must include 
both qualitative and quantitative methods in order to 
assure the identity and purity of the product. 
Qualitative analysis reveals the chemical identity of 
the analytes. Quantitative analysis gives the amount 
of one or more of these analytes in numerical terms. 
Therefore, qualitative information is required before a 
quantitative analysis. 
1.2 Different Methods of Analysis: Analytical 
chemistry can be split into two main types, 
A) Qualitative analysis 
B) Quantitative analysis 
A) Qualitative analysis: Qualitative inorganic 
analysis seeks to establish the presence of a given 
element or inorganic compound in a sample.
6
 
Qualitative analysis in chemistry focuses on a 
complete, detailed description of substances, 
processes, etc., in an attempt to get a thorough picture 
of what's going on. Mathematical descriptions are not 
generally part of qualitative analysis; instead, other 
observations are used to describe chemical properties 
and processes. This sort of analysis picks up 
otherwise-unclassifiable data, especially ambiguous 
data. But it is often not possible to extend the 
qualitative analysis description of one sample to other 
samples, largely because it is difficult or impossible 
to test findings of this nature. Typically, qualitative 
analysis by itself will not be done, but instead will be 
paired with quantitative analysis. Qualitative analysis 
makes a very good precursor for quantitative analysis; 
with a qualitative analysis, you can get a good idea of 
the items you want to later examine with a 
quantitative analysis.
7, 8
 
B) Quantitative analysis 
Quantitative analysis seeks to establish the amount of 
a given element or compound in a sample. 
Quantitative Analysis is classified into two types: 
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I) Classical methods: In Classical methods analysis 
were carried out by separating the component of 
interest in a sample by precipitation, extraction or 
distillation. For quantitative analysis the amount of 
analyte was determined by gravimetric or titrimetric 
measurements. 
Volumetric Method: It is based on the determination 
of a solution of known strength required to complete a 
chemical reaction with the substance being analyzed. 
Gravimetric Method: In this method, the assay 
results generally are obtained either by determining 
the weight of a substance in the sample, or the weight 
of some other substance derived from the sample, the 
equivalent weight of which serves as the basis for 
calculating the result. 
II) Instrumental methods: Instrumental methods 
involves measurement of physical properties of 
analyte such as conductivity, electrode potential, light 
absorption or emission, mass to charge ratio began to 
be used for quantitative analysis of variety of 
inorganic, organic and biochemical analyte. Further 
more highly efficient chromatographic, 
electrophoresis technique began to replace 
distillation, extraction and precipitation for separation 
of components of complex mixtures prior to their 
qualitative or quantitative determination. Thesenewer 
methods for separating and determining chemical 
species are known collectively as instrumental 
methods of analysis. These instruments vary in their 
principle method of detection as well in their 
objectives like quantitative and qualitative analysis. 
The method of analysis will also depend on their 
physical and chemical characters. Thermal sensitive 
products are not analyzed by thermal methods of 
analysis. Out of all these methods UV spectroscopy, 
FTIR, liquid chromatography, mass spectroscopy, etc. 
is used most frequently because they are easy for 
method development, operation, etc. Along with the 
method development its validation should be done for 
determination of analytical method consistency.
9, 10, 11 
 
1.3 Introduction to Chromatography
12,16: 
Chromatography was discovered by M. S. Tswett in 
1903 and can be described as a separation process that 
is achieved by distribution of substance between two 
phases, a stationary phase and mobile phase. Those 
solutes distributed preferentially in the mobile phase 
will move more rapidly through the system than those 
distributed preferentially in the stationary phase. 
Thus, the solute will elute in order of their increasing 
distribution coefficient with respect to the stationary 
phase. The basic principle behind chromatography 
method can be state as different distribution of the 
analytes between mobile and stationary phase results 
in different migration velocities. 
Chromatography is probably the most 
powerful and versatile analytical technique available 
to the modern chemist. Its versatility comes from its 
capacity to handle a very wide variety of samples can 
range in complexity from a single substance to 
multicomponent mixture containing widely differing 
chemical species. In analytical chemistry it is prime 
important to gain information about the qualitative 
and quantitative composition of substances and 
chemical species that is to find out what substance is 
composed of and exactly how much. Separation of 
two sample components in chromatography is based 
on their different distribution between two non-
miscible phases. The one is the stationary phase, a 
liquid or solid, is fixed in the system. The other is the 
mobile phase, a fluid, is streaming through the 
chromatographic system. 
1.4 High Performance Liquid Chromatography 
HPLC is high resolution, high pressure and 
high speed liquid chromatography. It has several 
times resolving power than open column liquid 
chromatography hence it is used for speedy resolution 
of complex mixture, separation and determination of 
species in a variety of organic, inorganic and 
biological materials.
9 
1.4.1 History of HPLC
17
 
During 1970's, most chemical separations 
were carried out using a variety of techniques 
including open-column chromatography, paper 
chromatography, and thinlayer chromatography. 
During this time, pressure liquid chromatography 
began to be used to decrease flow through time, thus 
reducing purification times of compounds being 
isolated by column chromatography. High pressure 
liquid chromatography was developed in the mid-
1970's and quickly improved with the development of 
column packing materials and the additional 
convenience of on-line detectors. In the late 1970's, 
new methods including reverse phase liquid 
chromatography allowed for improved separation 
between very similar compounds. By the 1980's 
HPLC was commonly used for the separation of 
chemical compounds. New techniques improved 
separation, identification, purification and 
quantification far above the previous techniques. 
Computers and automation added to the convenience 
of HPLC. Improvements in type of columns and thus 
reproducibility were made as such terms as micro-
column, affinity columns, and fast HPLC began to 
immerge. The past decade has seen a vast undertaking 
in the development of the microcolumns, and other 
specialized columns. The dimensions of the typical 
HPLC column are: 30 mm in length with an internal 
diameter between 3-5 mm. The usual diameter of 
micro-columns, or capillary columns, ranges from 3 
ȝm to 200 ȝm. Fast HPLC utilizes a column that is 
shorter than the typical column, with a length of about 
3 mm long, and they are packed with smaller 
particles. 
1.4.2 Classification of Liquid Chromatographic 
Methods 
18-21
 
There are two ways to classify liquid 
chromatographic methods. Classification according to 
mechanism of retention classification according to 
operating method 
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Fig. 1: Schematic drawings of a six-port Rheodyne 
valve 
                                     
 
1.4.3 HPLC theories
22-30
 
Two main aspects comprise HPLC theory Kinetic 
aspect of chromatographic zone migration is 
responsible for the band broadening Thermodynamic 
aspects are responsible for the analyte retention in the 
column. 
1.4.4 Basic Concepts of HPLC
23
 
Chromatography is described and measured in terms 
of four major concepts: capacity, efficiency, 
selectivity, and resolution. 
Dead time (t0): It is the time required by an inert 
compound to migrate from column inlet to column 
end without any retardation by the stationary phase. 
Consequently, the dead time is identical with the 
residence time of the sample compound in the mobile 
phase. 
Net retention time (tR1 or tR2): It is the difference 
between total retention time and dead time. That is 
the time the sample component remains in the 
stationary phase. 
                              
 
Tailing factor (T): It is a measure of peak symmetry, 
is unity for perfectly symmetrical peaks and its value 
increases as the tailing becomes more pronounced.  
                        
Where, A and B are determined by 10 % of 
peak height. 
Fig. 2: Instrumental parameter of 
chromatography. 
  Capacity factor (k’)μ For effective liquid 
chromatographic separations, a column must have the 
capacity to retain samples and the ability to separate 
sample components, efficiently. The capacity factor, 
k’R, of a column is a direct measure of the strength of 
the interaction of the sample with the packing 
material and is defined by the expression- 
 
Where tR is the time taken for a specific solute to 
reach the detector and to is the time taken for 
nonretained species to reach the detector. VR is the 
volume of solution that is pumped through the 
detector before a specific peak is eluted, and V0 is the 
volume of solvent pumped through the detector 
between the time of injection and the appearance of 
the nonretained species. The capacity factor of a 
column is mostly a function of the packing material 
but can be manipulated to a degree by varying the 
solvent strength. The higher the capacity factor of the 
column, the greater is its ability to retain solutes 
Selectivity (α)μ The selectivity of the 
chromatographic system is a measure of the 
difference in retention times between two given peaks 
and describes how effectively a chromatographic 
system can separate two compounds. Selectivity is 
usually defined in terms of α, where 
 
The selectivity of a column is primarily a function of 
the packing material, although the chromatographer 
has some control using the mobile phase or 
temperature. 
Resolution (R): Resolution is a term used to describe 
the degree of separation between neighbouring solute 
bands or peaks. It is affected by the selectivity (a), 
efficiency (N) and capacity (k') of the column. The 
resolution equation describes the relationship between 
those factors and indicates how they can be 
manipulated in order to improve the resolution 
between two peaks. 
 
Efficiency: Column efficiency refers to the 
performance of the stationary phase to accomplish 
particular separations. This entails how well the 
column is packed and its kinetic performance. The 
efficiency of a column, N, is a number that describes 
peakbroadening as a function of retention and is 
dependent on the entire chromatographic system. 
 
Height equivalent of a theoretical plate (h): HETP 
is the length, in which the chromatographic 
equilibrium between mobile and stationary phase is 
established. Since a large number of theoretical plates 
is desired, h should be as small as possible. 
 
Two theories have been developed to describe the 
efficiency of the column: The plate theory 
The rate theory The plate theory assumes that an 
instantaneous equilibrium is set up for the solute 
between the stationary and mobile phases, and it does 
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not consider the effects of diffusional effects on 
column performance. The rate theory avoids the 
assumption of an instantaneous equilibrium and 
addresses the diffusional factors that contribute to 
band broadening in the column, namely, eddy 
diffusion, longitudinal diffusion, and resistance to 
mass transfer in the stationary phase and the mobile 
phase. The experimental conditions required to obtain 
the most efficient system can be determined by 
constructing a van Deemter plot. 
1.4.4 Elution types 
Isocratic elution: A separation in which the mobile 
phase composition remains constant throughout the 
procedure is termed isocratic elution. In this elution, 
peak width increases with retention time linearly 
according to the equation for N, the number of 
theoretical plates. This leads to the disadvantage that 
late-eluting peaks get very flat and broad. Their shape 
and width may keep them from being recognized as 
peaks. In isocratic elution, the selectivity does not 
change if the column dimensions change. 
Gradient elution: A separation in which the mobile 
phase composition is changed during the separation 
process is described as a gradient elution. Gradient 
elution decreases the retention of the later-eluting 
components so that they elute faster, giving narrower 
peaks for most components. This also improves the 
peak shape for tailed peaks, as the increasing 
concentration of the organic eluent pushes the tailing 
part of a peak forward. This also increases the peak 
height, which is important in trace analysis. The 
elution order may change as the dimensions or flow 
rate change. 
1.4.5 Instrumentation for high performance liquid 
chromatography 
26-30
 
The basic components of a high-performance liquid 
chromatographic system consists of a) eluent 
containers for the mobile phase, b) a pump to move 
the eluent and sample through the system, c) an 
injection device to allow sample introduction, d) a 
column(s) to provide solute separation, e) a detector 
to visualize the separated components, f) a waste 
container for the used solvent, and g) a data collection 
device to assist in interpretation and storage of results. 
Mobile phase reservoir, filtering system: The most 
common type of solvent reservoir is a glass bottle. 
Most of the manufacturers supply these bottles with 
the special caps, Teflon tubing and filters to connect 
to the pump inlet and to the purge gas used to remove 
dissolved air. Helium purging and storage of the 
solvent under helium was found not to be sufficient 
for degassing of aqueous solvents. It is useful to apply 
a vacuum for 5-10 min. and then keep the solvent 
under a helium atmosphere. 
Pumps: High pressure pumps are needed to force 
solvents through packed stationary phase beds. 
However, many separation problems can be resolved 
with larger particle packing that requires less 
pressure. Modern pumps have the following 
parameters: Flow rate range: 0.01 to 10 ml/min, Flow 
rate stability: not more than 1%, For SEC flow rate 
stability should be less than 0.2%, Maximum 
pressure: up to 5000 psi (345 bar, 340 atm) 
The pumps are categorized as – 
Constant displacement pump: It is a low-pulsation 
displacement pump comprises two series-connected 
cylinders, which are controlled by valves so that the 
delivery takes place only in one direction. The pistons 
of the cylinders are controlled through cams which 
are driven jointly at a constant velocity. 
Reciprocating pump: The piston expels liquid 
through a one-way valve (check valve). The pumping 
rate is usually adjusted by controlling the distance the 
piston retracts, thus limiting the amount of liquid 
pushed out by each stroke, or by the cam rotating 
speed. 
 
                  Fig. 3: Instrumentation for High-Performance Liquid Chromatography 
3 
 
Injection device: Injectors for liquid 
chromatographic systems should provide the 
possibility of injecting the liquid sample within the 
range of 0.1 to 100 ml of volume with high 
reproducibility and under high pressure (up to the 
4000 psi). They should also produce minimum band 
broadening and minimize possible flow disturbances. 
Generally, the most useful and widely used sampling 
device for modern LC is the microsampling injector 
valve. Because of their superior characteristics, valves 
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are now used almost to the exclusion of syringe 
injection. With these sampling valves, samples can be 
introduced reproducibly into pressurized columns 
without significant interruption of flow, even at 
elevated temperatures. 
1.5 DRUG PROFILE 
1.5.1 Etodolac 
39 
 
Figure .4: Structure of Etodolac 
Chemical name: (RS)-2-(1,8-Diethyl-4,9-dihydro-
3H-pyrano[3,4-b] indol-1-yl)acetic acid 
Molecular formula: C17H21NO3. 
Molecular weight: 287.35 gm/mol, 
Appearance: White to slightly yellowish crystals or 
crystalline powder. 
Solubility: Soluble in methanol & nearly insoluble in 
water 
Category: Etodolac is an anti-inflammatory agent 
with analgesic and antipyretic properties. 
Dose: Oral Osteoarthritis 
Adult: 600-1000 mg/day in divided doses adjusted 
according to response. 
Max Dosage: 1200 mg daily. Oral Rheumatoid 
arthritis 
Adult: 600-1000 mg/day in divided doses adjusted 
according to response. 
Max Dosage: 1200 mg daily. Oral Acute pain. 
Identification: The light absorption in the range 230 
nm to 360 nm of a 0.01% w/v solution in methanol 
exhibits maxima at about 302 nm. 
Storage: Store in a cool, dry and dark place. 
Pharmacology: Decreases inflammation, pain, and 
fever, probably through inhibition of cyclooxygenase 
activity and prostaglandin synthesis Etodolac is an 
NSAID. Exactly how it works is not known. It may 
block certain substances in the body that are linked to 
inflammation. NSAIDs treat the symptoms of pain 
and inflammation. They do not treat the disease that 
causes those symptoms. Etodolac is an anti-
inflammatory agent with analgesic and antipyretic 
properties. It is used to treat osteoarthritis, rheumatoid 
arthritis and control acute pain. The therapeutic 
effects of Etodolac are achieved via inhibition of the 
synthesis of prostaglandins involved in fever, pain, 
swelling and inflammation. Etodolac is administered 
as a racemate. As with other NSAIDs, the S-form has 
been shown to be active while the R-form is inactive. 
Both enantiomers are stable and there is no evidence 
of R- to S- conversion in vivo. 
Adverse effects: Etodolac is generally well tolerated 
and side effects usually are transient reported side 
effects includes; 1) Headache, 2) nausea, 3) dizziness. 
4) Diarrhoea, 5) vomiting, 6) abdominal pain. 7) Joint 
pain, 8) arthritis, 9) vaginitis 10) skin rash. 
Uses: An anti-inflammatory agent with analgesic and 
antipyretic properties is used to treat osteoarthritis and 
control acute pain. 
 
Figure 5: Structure of Paracetamol 
1.5.2. Paracetamol 
4 
         
 
Chemical name: N-(4-hydroxyphenyl) acetanilide, 
Molecular formula: C8H9NO2. 
Molecular weight: 151.17g/mol,  
Category: Paracetamol is used as an Analgesic and 
Antipyretic. Appearance: A white or almost white 
crystalline powder. 
Solubility: Paracetamol is soluble in methanol. 
Dose: Initial dose of Paracetamol is 250 mg per day. 
Pharmacology: Paracetamol exhibit analgesic action 
by peripheral blockage of pain impulse generation .It 
produces antipyresis by inhibiting the hypothalamic 
heat regulating centre. It is weak anti-
inflammamatory activity is related to inhibition 
ofprostaglandin synthesis in the central nervous 
system. 
Pharmacokinetics: Paracetamol (acetaminophen) is 
generally considered to be a weak inhibitor of the 
synthesis of prostaglandins (PGs). However, the in 
vivo effects of paracetamol are similar to those of the 
selective cyclooxygenase-2 (COX-2) inhibitors. 
Paracetamol also decreases PG concentrations in 
vivo, but, unlike the selective COX-2 inhibitors, 
paracetamol does not suppress the inflammation of 
rheumatoid arthritis. It does, however, decrease 
swelling after oral surgery in humans and suppresses 
inflammation in rats and mice. Paracetamol is a weak 
inhibitor of PG synthesis of COX-1 and COX-2 in 
broken cell systems, but, by contrast, therapeutic 
concentrations of paracetamol inhibit PG synthesis in 
intact cells in vitro when the levels of the substrate 
arachidonic acid are low (less than about 5 mol/L). 
Adverse Effects: Very common: More than 1 in 10 
people who take Paracetamol 
Common: More than 1 in 100 people who take 
Paracetamol. 
Confusion, Constipation, Diarrhoea, Dry mouth, 
Euphoria, feeling anxious, feeling nervous, 
Flatulence, Headaches, Indigestion, itching, Mood 
changes, Sleeping problems, Stomach pain,  sweating, 
trembling, Vomiting. 
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2. Methodology 
2.1 Determination of Ȝmax of Etodolacμ 
 
              Figure 6: UV spectra of Etodolac 
The standard solution of Etodolac was scanned at 
different concentrations in the range of 200-400 nm 
and the Ȝmax was found to be 302 nm against reagent 
blank. 
2.2 Determination of Ȝ max of Paracetamolμ 
        
 
Figure 7: UV spectra of Paracetamol    
The standard solution of Paracetamol was scanned at 
different concentrations in the range of 200-400 nm 
and the Ȝ max was found to be 240 nm against 
reagent blank 
RP-HPLC Method for Etodolac and Paracetamol. 
Determination of Etodolac and Paracetamol in 
combined tablet dosage form. 
METHOD 
Solubility of drugs in different solvents: Solubility 
of both drugs was observed by dissolving them in 
different solvents.                          
Table 1: Solubility of drugs in different solvents: 
Solvents Solubility 
Etodolac Paracetamol 
ACN + + 
Water + ++ 
Methanol +++ +++ 
Methylene + + 
(+++) Symbolizes highly soluble, (++) Symbolizes 
freely soluble, (+) Symbolizes soluble. 
 
Method: 
A. Selection of analytical wavelength: By 
appropriate dilution of each standard stock solution 
with methanol, various concentrations of Etodolac 
and Paracetamol were prepared separately. Each 
solution was scanned in between the range of 200 nm 
to 400 nm and their spectra were overlaid. The 
wavelength selected for the analysis was 235 nm 
which both the drugs showed significant absorbance. 
The overlain UV spectra of Etodolac and Paracetamol 
in the methanol are as shown in figure below. 
         
 
Figure 8: Overlain spectra of Etodolac and 
Paracetamol 
B. Calibration of Etodolac & Paracetamol: Take 10 
mg of Etodolac & 10 mg of Paracetamol separately in 
100 mL volumetric flask which was then dissolved in 
40 mL mobile phase with shaking. Then it was 
sonicated for 15 min and the volume was made up to 
100 mL. Suitable dilutions are made from the 
standard stock solutions. The linearity of the 
relationship between peak area and concentration was 
determined by analyzing six working standards over 
the concentration range of 10, 20, 30, 40, 50 and 
100ȝg/mL for Etodolac and 10, 20, 30, 40, 50 and 
100ȝg/mL for Paracetamol. Hence the peak areas 
were recorded against concentration and graph of 
concentration Vs peak area was plotted. 
 
Figure 9: Chromatogram of 10 ȝg/mL of Etodolac 
 Figure 10μ Chromatogram of 100 ȝg/mL of 
Etodolac 
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Figure 11 : Calibration curve of Etodolac 
 
Chromatogram of Paracetamol; 
 Figure 12μ Chromatogram of 10 ȝg/mL of 
Paracetamol 
 Figure 13μ Chromatogram of 100 ȝg/mL of 
Paracetamol 
 
Figure 14: Calibration curve of Paracetamol 
 
Table 2: Calibration of Etodolac and Paracetamol 
 Conc (ȝg/ml) Area (ȝv.sec) 
Etodolac Paracetamol Etodolac Paracetamol 
1 10 10 93498.0 91746.0 
2 20 20 188453.5 181902.1 
3 30 30 291273.8 245698.7 
4 40 40 368876.9 348948.0 
5 50 50 469843.8 419603.4 
6 100 100 939803.8 8473311.8 
             
C. Selection of mobile system: The pure drug of 
Etodolac and Paracetamol were injected into HPLC 
system by using different solvent systems. Different 
mobile phases like acetonitrile: methanol: water, 
acetonitrile:  methanol: potassium dihydrogen 
phosphate buffer, were tried in order to find the 
optimum conditions for the separation of Etodolac 
and Paracetamol. Finally the optimum composition of 
the mobile phase was selected as methanol (60 mL) 
mixed with 25 mM phosphate buffer (40 mL), whose 
pH was adjusted to 6.1 by orthophosphoric acid 
which gave satisfactory results with sharp well 
defined and well resolved peaks and acceptable peak 
parameters as compared to other mobile phases. 
D. Preparation of mobile phase: Methanol (60 mL) 
was mixed with 25 mM phosphate buffer (40 mL), 
and then pH was adjusted to 6.1 by addition of ortho-
phosphoric acid. 
E. Degassing the mobile phase: The mobile phase 
prepared was degassed by ultrasonication for about 15 
min, so as to avoid the disturbances caused by 
dissolved gases. 
F. Filtration of mobile phase: The mobile phase 
after degassing was filtered through 0.45 ȝm 
membrane nylon filter to remove the smaller particles 
that may be present in the mobile phase and which 
may cause clogging of column. 
G. Preparation of standard stock solutions: 10 mg 
of Etodolac and 10 mg of Paracetamol were weighed 
separately and dissolved in 40 mL of mobile phase 
with shaking. Then it was sonicated and the volume 
was made upto 100 mL by using mobile phase. From 
standard stock solution of drug, appropriate dilutions 
were made using the mobile phase and the sample 
was filtered through 0.2 ȝm of clear filtrate were 
injected into the HPLC column. 
H. Loading of mobile phase: Filtered and degassed 
mobile phase was loaded in the reservoir. Priming 
was done for each freshly prepared mobile phase. 
I. Baseline stabilization: The detector was turned on 
for an hour before the actual run in order to obtain the 
stable UV light. The mobile phase run was started at 
desired flow rate and the run was continued until the 
stable baseline was obtained. 
J. Loading of samples: Well prepared and filtered 
samples of Etodolac and Paracetamol were loaded 
into the Rheodyne injector port using a syringe and 
the sample was then injected. 
K. Washing the column: Once the analysis of 
samples was finished, the column was first washed by 
flushing with the mobile phase for half an hour, 
afterwards with double distilled water and methanol 
in 1:1 proportion for another one hour. 
L. Selection and Optimization of HPLC method: 
After the selection of suitable mobile phase, it was 
then optimized for its reproducibility, sensitivity and 
accuracy. 
M. Chromatogram of working standard for 
Etodolac and Paracetamol 
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Figure 15: Chromatogram of working standard of 
20 ȝg/ml of Etodolac 
 
Figure 16: Chromatogram of working standard of 
20ȝg/ml of Etodolac and 50ȝg/ml of Paracetamol 
 
Table. 3 : Details of chromatogram of working standard containing Etodolac and Paracetamol. 
Sr. 
No 
Name RT 
(min) 
Area  
(ȝv.sec) 
Theoritical 
plates 
Reaolution Asymmetry 
1 Etodolac 3.19 164729.6 2508.36 2.53 1.51 
2 paracetamol 6.09 424509.4 3703.55 2.43 1.63 
      
N. Analysis of Tablet formulation: 
Brand: ETOVA-P, Manufacturer: Intas 
Pharmaceuticals 
Each Tablet contains: Etodolac 200mg, Paracetamol 
500 mg 
Procedure: Take twenty tablets, each containing 200 
mg of Etodolac and Paracetamol 500 mg. The tablets 
were crushed to fine powder and amount of powder 
equivalent 100 mg of Etodolac and 250 mg 
Paracetamol were weighed and transferred to100 mL 
dried volumetric flask. Sufficient amount of mobile 
phase was added to dissolve the content and shaken 
for 15 min. The volume was made up to 100 mL with 
mobile phase. Then solution was filtered by using 
membrane filter and degassed. From this solution 
appropriate dilutions of Etodolac and Paracetamol 
were made to get the final concentrations and injected 
into the system to get the chromatogram. The 
chromatogram obtained is shown in Figure 18.  And 
the area obtained in each chromatogram of five 
replicate was correlated with regression equation and 
the amount found is calculated which was within the 
limit of label claim as mentioned in Table 3. 
                          
 
Figure 17: Chromatogram of Etodolac (20 ȝg/mL) 
and Paracetamol (50 ȝg/mL) in Tablet 
Formulation. 
Table. 4: Details of chromatogram of (20 ȝg/mL) Etodolac and (50 ȝg/mL) Paracetamol Tablet. 
Sr. No Name RT(min) Area (ȝv.sec) Theoretical plates Resolution Asymmetry 
1 Etodolac 3.192 184729.6 2708.36 2.53 1.31 
2 paracetamol 6.092 424509.4 3003.55 2.43 1.53 
 
Table 5: Analysis of ETOVA-P Tablet. 
Sl. No Amount present (ȝg/ml) Amount found (ȝg) % Label claim 
Etodolac Paracetamol Etodolac Paracetamol Etodolac Paracetamol 
1 20 50 19.56 49.54 99.90 99.76 
2 20 50 19.74 49.58 99.45 99.56 
3 20 50 19.44 49.87 99.65 99.81 
4 20 50 19.43 49.65 99.48 99.72 
5 20 50 19.52 49.58 99.51 99.56 
 
O. Evaluation of analytical method (Method 
validation): 
Linearity and sensitivity: Suitable dilutions of 
different concentrations using mobile phase were 
made from the standard stock solutions. The linearity 
of the relationship between peak area and 
concentration was determined by analyzing six 
working standards over the concentration range 10-
100 ȝg/ml for Etodolac and 10-100 ȝg/ml for 
Paracetamol. Here the peak areas were recorded 
against concentration and graph of concentration Vs 
peak area was plotted. Results obtained are shown in 
Table 6. 
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Table 6: Linearity of Etodolac. (n=3) 
Standard conc. 10 ȝg/ml 20 ȝg/ml 30 ȝg/ml 40 ȝg/ml 50 ȝg/ml 100 ȝg/ml 
Replicates Peak area  
1 95574.0 188250.4 291073.8 370980.6 470809.3 940467.7 
2 93573.1 189609.1 291081.4 366817.3 474861.9 941178.3 
3 94895.6 188151.7 291426.4 368709.9 476574.1 945799.6 
Mean 94680.9 188670.4 291193.9 368835.9 474081.8 942481.9 
± SD 1017.581 814.431 201.415 2084.510 2960.521 2895.126 
% RSD 1.0747 0.4316 0.0691 0.5651 0.6244 0.3071 
 
 
Figure 18: Calibration plot of Etodolac 
 
Table 7: Linearity Paracetamol. (n=3) 
Standard conc. 10 ȝg/ml 20 ȝg/ml 30 ȝg/ml 40 ȝg/ml 50 ȝg/ml 100 ȝg/ml 
Replicates Peak area  
1 91574.0 178250.4 261073.8 340980.6 440809.3 870467.7 
2 92573.1 179609.1 251081.4 346817.3 424861.9 841178.3 
3 91895.6 178151.7 251426.4 348709.9 426574.1 845799.6 
Mean 91680.9 178670.4 251193.9 348835.9 424081.8 842481.9 
± SD 317.581 414.431 5301.415 5084.510 2260.521 2395.126 
% RSD 0.3747 0.2316 1.8691 1.4651 0.6244 0.3071 
 
 
Figure 19: Calibration of Paracetamol 
Precision: Repeatability of method was established 
by analyzing various replicates standards of Etodolac 
and Paracetamol. All the solutions were analyzed 
thrice, in order to record any intra-day and inter-day 
variation in the result. The result obtained for intraday 
variations are shown in Table 8 and Table 9. And the 
result obtained for inter-day variations are shown in 
the Table 10 and Table 11. 
 
Table 8: Intra-day variability of Etodolac 
 Conc. 
(ȝg/ml) 
Peak area (ȝV.sec) Mean area 
(ȝV.sec) ±SD % RSD Trial 1 Trial 1 Trial 1 
20 182980.4 187634.8 185643.9 187654.7 3706.217 1.9868 
30 294396.5 295396.5 298396.5 294696.5 294696.5 0.6868 
40 371238.2 379238.2 371838.2 371438.2 745.845 0.2101 
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Table 9: Intra-day variability of Paracetamol 
Conc. 
(ȝg/ml) 
Peak area (ȝV.sec) Mean area 
(ȝV.sec) 
±SD 
 
% RSD 
 Trial 1 Trial 1 Trial 1 
20 182180.4 183634.8 185143.9 187654.7 406.217 0.9868 
30 264396.5 275396.5 258396.5 264696.5 2410.5 0.6868 
40 341238.2 359238.2 351838.2 341438.2 2745.845 0.86 
 
Table 10: Inter-day variability of Etodolac 
Conc. 
(ȝg/ml) 
Peak area (ȝV.sec) Mean 
area(ȝV.sec) 
±SD % RSD 
Day 1 Day2 Day3 
20 182240.4 187104.8 182343.9 183054.7 3711.217 1.6868 
30 294396.5 295396.5 298396.5 294696.5 1696.5104s 0.6868 
40 371238.2 379238.2 371838.2 371438.2 545.845 0.2117 
 
Table 11: Inter-day variability of Paracetamol 
Conc. 
(ȝg/ml) 
Peak area (ȝV.sec) Mean area 
(ȝV.sec) 
±SD % RSD 
Day 1 Day2 Day3 
20 182740.4 187464.8 186343.9 183054.7 3711.217 0.1368 
30 254396.5 265396.5 268396.5 264696.5 3696.510 0.368 
40 371238.2 379238.2 371838.2 371438.2 545.845 2.117 
  
Accuracy: To check the accuracy of proposed 
method, level of recovery carried out at 80, 100 and 
120% of the concentration as per standard addition 
method. Here the product was accessed by addition of 
series of known amount of standard drug in the 
product and then the contents were estimated by assay 
method. The % recovery for Etodolac and 
Paracetamol is in the range. Results are shown in 
Table 12.  
Table.12: Recovery studies of Etodolac and Paracetamol. 
Tablet 
Sample 
Level of 
recovery 
% 
Amount taken 
(ȝg/ml) 
 
Amount of 
standard added 
(ȝg/ml) 
Total amount  
recovered  
(ȝg/ml) 
 
% Recovery 
 
 
 
 
 
ETOVA-P 
Drug ET PCM ET PCM ET PCM ET PCM 
80 20 50 16 40 35.56 89.34 99.34 99.64 
80 20 50 16 40 35.45 89.56 99.43 99.53 
80 20 50 16 40 35.76 89.67 99.65 99.75 
100 20 50 20 50 39.57 99.23 99.32 99.42 
100 20 50 20 50 39.68 99.49 99.53 99.63 
100 20 50 20 50 39.81 99.51 99.38 99.48 
120 20 50 24 60 43.42 108.66 99.56 99.66 
120 20 50 24 60 43.56 108.45 99.89 99.99 
120 20 50 24 60 43.78 108.76 99.44 99.54 
 
Table.13: Statistical Validation of ETOVA- P 200 Tablet 
Level of % recovery % Mean ±SD %RSD 
 ET PCM ET PCM ET PCM 
80 99.75 99.82 0.1852 0.1234 0.1955 0.1126 
100 99.54 99.74 0.3771 0.1156 0.3788 0.1158 
120 99.28 99.85 0.4265 0.0987 0.4317 0.0972 
 
Limit of detection (LOD): LOD is calculated from 
the formula 
LOD = 3.3σ/S, σ= Standard deviation of the response, 
s = slope of the calibration curve 
Etodolacμ 0.10123 ȝg/mL, Paracetamolμ 0.0λ861 
ȝg/mL 
Limit of Quantitation (LOQ): LOQ is calculated 
from the formula LOQ=10σ/S 
σ= Standard deviation of the response S= slope of the 
calibration curve 
Etodolacμ 0.21λ3 ȝg/mL, Paracetamolμ 0.1λ50λ 
ȝg/mL 
Linearity Range: The range shown by is given as 
follows 
Etodolac: 10-100 ȝg/mL, Paracetamolμ 10-100 ȝg/mL 
Robustness: Robustness of the method was 
determined by carrying out the analysis under 
conditions during which mobile phase ratio and pH 
was altered. Variation of mobile phase pH and ratio 
are seemed to have greater impact on resolution and 
hence it should be meticulously controlled. 
Analysis of tablet formulation: After analysis of all 
the different brands of tablets the amount found is 
calculated which was within the limit of label claim. 
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Figure 20: Chromatogram of Etodolac (20 ȝg/mL) and Paracetamol (50 ȝg/mL tablet) in Tablet 
Formulation. 
 
Table 14: Analysis of tablet 
Sr. No. Amount present in (ȝg) Amount found in (ȝg) % Label claim 
ET PCM ET PCM ET PCM 
1 20 50 19.95 49.78 99.92 99.82 
2 20 50 19.90 49.87 99.45 99.35 
3 20 50 19.89 49.67 99.83 99.73 
4 20 50 19.97 49.54 99.56 99.46 
5 20 50 19.87 49.83 99.89 99.79 
       
3. Result And Discussion 
3.1 HPLC Method: RP-HPLC method was 
developed and validated for estimation of Etodolac 
and Paracetamol from bulk drug and tablet 
formulation. Method was validated by using different 
parameters likes linearity, precision, accuracy, and 
limit of detection, limit of quantitation, specificity, 
range and robustness. Method of RP High 
performance liquid chromatography has been 
successfully employed for simultaneous estimation of 
Etodolac and Paracetamol from bulk and tablet 
dosage form. Method was validated as per ICH and 
USP guidelines by using different parameters like 
linearity, precision, accuracy, limit of detection, limit 
of quantitation, specificity, range and robustness. The 
linearity of Etodolac was observed in the range of 10-
100 ȝg/mL and that of Paracetamol was in the range 
of 10-100 ȝg/mL. Detection wavelength used was 235 
nm with correlation coefficient 0.999 and 0.998 for 
Etodolac and Paracetamol respectively. The limit of 
detection was found to be 0.10123 ȝg/mL and 
0.0λ861 ȝg/mL for Etodolac and Paracetamol 
respectively and limit of quatitation 0.21λ3 ȝg/mL 
and 0.1λ50λ ȝg/mL for Etodolac and Paracetamol 
respectively. The percent relative standard deviation 
and high percent recovery data were satisfactory and 
confirms accuracy, precision and reliability of the 
method. Thus the methods are simple, accurate, 
precise, economical and reproducible for routine 
estimation of Etodolac and Paracetamol respectively 
from bulk drug and formulations. 
 
4. Conclusion 
The proposed method was found to be Simple, 
Accurate, Precise, economical, Reproducible. 
The sample assay results and recoveries in tablets 
were in good agreement with their respective label 
claims and added standard sample, and thus, 
suggested noninterference of formulation excipients 
in the estimation. Hence the propose method can be 
used for the routine quality control analysis of 
Etodolac and Paracetamol in bulk drug as well as 
tablet formulations. 
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